Delayed rectovaginal fistula: a potential complication of bevacizumab (avastin).
Ley
Eric J
EJ
Vukasin
Petar
P
Kaiser
Andreas M
AM
Ault
Glenn
G
Beart
Robert W
RW
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D012004:Rectal Neoplasms / Q000473:pathology / Q000601:surgery; D012006:Rectovaginal Fistula / Q000139:chemically induced*; D013997:Time Factors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab